Boryung Corporation (formerly Boryung Pharmaceutical Co., Ltd.) is a South Korean life-science and healthcare conglomerate that, acting as the investment arm of its operating parent, deploys corporate venture capital into startups spanning pharmaceuticals, biotech, and space-based healthcare. Since 2022, it has invested $50 million in Axiom Space's Series C round, partnered with Starburst Aerospace to run the Care In Space accelerator program, and created the BRAX Space joint venture.
Average disclosed round size is $5.7M (across 3 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
JW
Jinsol Woo
Investment Team, Business Strategic Division
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Exobiosphere | Seed | — | Apr 2025 |
 LambdaVision | Unknown | $17M | May 2024 |
 Axiom Space | Growth | — | Aug 2023 |
| DDeep Space Biology | Unknown | $100K | — |
| VViBo Health | Unknown | $100K | — |
Top Co-Investors
Last updated: 27 September 2026